Prazitone information

Prazitone
Clinical data
Other names	5-phenyl-5-(2-piperidylmethyl)barbituric acid
ATC code	none;
Identifiers
	IUPAC name 5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	2409-26-9 ;
PubChem CID	3050417;
ChemSpider	2312482 ;
UNII	6DZB018428;
CompTox Dashboard (EPA)	DTXSID80862926 ;
Chemical and physical data
Formula	C16H19N3O3
Molar mass	301.346 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CCNC(C1)CC2(C(=O)NC(=O)NC2=O)C3=CC=CC=C3;
	InChI InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22) ; Key:UGZAKKMLMJITLL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.^[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.^[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.

^ DE Patent 1645911
^ Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596

[1] DE Patent 1645911

[2] Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596

Prazitone information

and 28 Related for: Prazitone information

Prazitone

Ciprofloxacin

Itraconazole

Vardenafil

Sildenafil

Levodropropizine

C16H19N3O3

Cyclizine

Vilazodone

Ranolazine

Imatinib

Trimetazidine

Benzylpiperazine

Piperazine

Diethylcarbamazine

PIPES

Phenylpiperazine

Trifluoromethylphenylpiperazine

Dropropizine

Dasatinib

Substituted piperazine

Azapirone

Posaconazole

Pyrimidinylpiperazine

Levoketoconazole

Flibanserin

Aripiprazole lauroxil

Alnespirone